Your browser doesn't support javascript.
loading
The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers.
McCarthy, Andrew P; Svensson, Kjell A; Shanks, Elaine; Brittain, Claire; Eastwood, Brian J; Kielbasa, William; Biglan, Kevin M; Wafford, Keith A.
Afiliación
  • McCarthy AP; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.) mccarthy_andrew_peter@lilly.com.
  • Svensson KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Shanks E; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Brittain C; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Eastwood BJ; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Kielbasa W; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Biglan KM; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
  • Wafford KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
J Pharmacol Exp Ther ; 380(3): 143-152, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34893551
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vigilia / Fármacos Neuroprotectores Tipo de estudio: Clinical_trials Límite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vigilia / Fármacos Neuroprotectores Tipo de estudio: Clinical_trials Límite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2022 Tipo del documento: Article